| P2093 | author name string | Ming Zhang | |
| | Fei Chen | |
| | Xin Su | |
| | Yi Shi | |
| | Ting Wu | |
| | Xiao-Yong Xu | |
| | Wen-Kui Sun | |
| P2860 | cites work | Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis | Q39652561 |
| | Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. | Q42286250 |
| | A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients | Q44355090 |
| | Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin | Q44469440 |
| | Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus | Q44619968 |
| | Combination antifungal therapy for invasive aspergillosis | Q45096994 |
| | Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis | Q46868249 |
| | Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study | Q46943408 |
| | Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis | Q46971553 |
| | The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. | Q51191763 |
| | Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis | Q56993324 |
| | Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 |
| | Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America | Q28263689 |
| | Quality assessment of reporting of animal studies on pathogenesis and treatment of peri-implant mucositis and peri-implantitis. A systematic review using the ARRIVE guidelines | Q34245735 |
| | Efficacy of micafungin alone or in combination against systemic murine aspergillosis | Q34884594 |
| | Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis | Q35007030 |
| | Pharmacokinetics and pharmacodynamics in the development of antifungal compounds. | Q35543291 |
| | Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination | Q35756513 |
| | In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model. | Q36048229 |
| | In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model. | Q36425025 |
| | Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality | Q36715387 |
| | Pulmonary aspergillosis: a clinical update | Q36831494 |
| | Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 |
| | Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin | Q37190801 |
| | Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis | Q37204192 |
| | Paradoxical echinocandin activity: a limited in vitro phenomenon? | Q37405284 |
| | Guidelines for reporting experiments involving animals: the ARRIVE guidelines | Q39512979 |
| P433 | issue | 2 | |
| P921 | main subject | aspergillosis | Q259626 |
| | invasive aspergillosis | Q3625278 |
| P304 | page(s) | 99-108 | |
| P577 | publication date | 2014-02-01 | |
| P1433 | published in | Journal of thoracic disease | Q26841814 |
| P1476 | title | Efficacy of combination therapy of triazole and echinocandin in treatment of invasive aspergillosis: a systematic review of animal and human studies | |
| P478 | volume | 6 | |